Heptares Therapeutics, the leading GPCR drug discovery and development company, announces the publication of a scientific article describing the high resolution X-ray crystal structure of the corticotropin-releasing factor receptor 1 (CRF1) receptor. The paper has been published in Nature and is available online to subscribers by clicking here. CRF1 is the receptor for the hormone CRF, which is important in regulating the body's response to stress and is implicated in stress-related diseases such as depression and anxiety...
More...
More...